
October 4, 2014	Web Version \| Share with a colleague \| eNews Subscribe	You are subscribed to the FormularyWatch eNews

First long-term treatment for DME approved by FDA

FDA has approved fluocinolone acetonide intravitreal implant (Iluvien, Alimera) 0.19 mg for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure. » Read about this newly US-approved drug

FDA OKs Relistor for opioid-induced constipation in chronic non-cancer pain

FDA approved methylnaltrexone bromide (Relistor, Salix Pharmaceuticals and Progenics Pharmaceuticals) subcutaneous injection, 12 mg/0.6 mL, for the treatment of opioid-induced constipation in patients taking opioids for chronic non-cancer pain. » Read about the phase 3 trial on which the approval was based

#icymi